This holiday season, we thank you for your ongoing support. We’re making great strides – with your help – to create a world where no one dies of lung cancer.
2018 has seen advancements in every aspect of lung cancer research. Lung cancer is driving forward the fields of precision medicine and immuno-oncology. We’re understanding what causes resistance to therapies, seeing progress in early detection – and, for the first time in over 35 years, there are improvements in the treatment of small cell lung cancer.
I am proud to say that LUNGevity is helping drive these changes forward as well as driving change in how people are living with the disease.
LUNGevity has become the largest and most impactful lung cancer non-profit in the nation.
- We are providing education and support to thousands of people across the country and the globe. We’re expanding the annual HOPE Summit in Washington, DC, to become a full-blown International Lung Cancer Survivorship Conference that will include sessions for newly diagnosed patients, caregivers, and long-term survivors.
- LUNGevity is committed to making sure that patients have access to precision medicine – or biomarker-driven care. We are also convening meetings with the FDA, regulators, industry partners, and clinicians to tackle some of the biggest obstacles standing in the way of patients accessing clinical trials and new lifesaving therapies.
- We are funding millions of dollars of transformative science:
--Our investment in research is paying dividends in the data being generated and the additional funding our scientists receive. Many of our younger investigators have been able to start their own labs because they received a LUNGevity Career Development Award.
--We are excited about our collaboration with SU2C and the American Lung Association to find lung cancer early when it is most treatable and intercepting it before it has the chance to metastasize. This $7MM investment over 4 years will revolutionize how we detect lung cancer and stop the disease before it gets going.
Together, we will continue to press forward to improve outcomes for patients and their families.
We wish you a happy holiday
season and look forward to 2019.
Andrea Ferris
President and CEO, LUNGevity Foundation
P.S. The latest edition of our Fresh Air newsletter is now available online.